Press Releases

NPS Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today that the U.S. Food and Drug Administration’s (FDA) Gastrointestinal Drugs Advisory Committee voted unanimously to recommend approval of Gattex® (teduglutide)...

Vince & Associates Clinical Research announced today that it provided platinum sponsorship of the 6th Annual Pain Therapeutics Summit held October 3-4, 2012, in San Jose, Calif. The conference convened multidisciplinary industry colleagues to discuss...

Starting today, seniors and their caregiverscan stop by any Rite Aid pharmacy for a free personalized Medicare Part D consultation with a Rite Aid pharmacist or use Rite Aid's dedicated Medicare Advisor comparison tools online at www.riteaid.com. Appointments...

  Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the award of a EUR 1 million grant to support the Translate-MS-Repair...

Eli Lilly & Co.’s solanezumab and Roche Holding AG’s gantenerumab were selected for a long-term Alzheimer’s trial run by Washington University at St. Louis scientists seeking to block the disease’s symptoms. The experimental medicines...

Recipharm AB and Astimex Pharma AB have today announced the formation of a collaboration agreement for the development and manufacture of a pharmaceutical product. The formulation development work will take place at the Recipharm...

Cytheris SA, a privately held clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today the publication of a paper demonstrating that Cytheris' CYT107, glycosylated recombinant human interleukin-7 (glycosylated r-h-IL7) can enhance immune T cell recovery after...